http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/name | "EMBO J."xsd:string |
http://purl.uniprot.org/citations/15152192 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/15152192 |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/date | "2004"xsd:gYear |
http://purl.uniprot.org/uniprot/Q8IUX4#attribution-5A7067A6046CF608D68F14081D6412C9 | http://purl.uniprot.org/core/source | http://purl.uniprot.org/citations/15152192 |
http://purl.uniprot.org/citations/15152192 | http://purl.org/dc/terms/identifier | "doi:10.1038/sj.emboj.7600246"xsd:string |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/author | "Cullen B.R."xsd:string |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/title | "A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins."xsd:string |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/volume | "23"xsd:string |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/author | "Wiegand H.L."xsd:string |
http://purl.uniprot.org/citations/15152192 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/15152192 |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/pages | "2451-2458"xsd:string |
http://purl.uniprot.org/citations/15152192 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/uniprot/Q8IUX4 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/15152192 |
http://purl.uniprot.org/uniprot/#_Q8IUX4-citation-15152192 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/15152192 |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/author | "Doehle B.P."xsd:string |
http://purl.uniprot.org/citations/15152192 | http://purl.uniprot.org/core/author | "Bogerd H.P."xsd:string |